12 results
8-K
EX-10.1
SRNEQ
Sorrento Therapeutics, Inc.
20 Oct 20
Departure of Directors or Certain Officers
5:21pm
by the Company may be used by the Company for any corporate purpose, and the Company shall not be obligated to segregate such payroll deductions.
(e) On each
8-K
EX-10.1
SRNEQ
Sorrento Therapeutics, Inc.
3 May 19
Entry into a Material Definitive Agreement
4:01pm
may be retained by the Borrower and used for any general corporate purpose not prohibited by this Agreement.
(e) Any prepayments required pursuant
8-K/A
EX-99.1
peypnjil ha
3 Apr 19
Other Events
1:14pm
424B5
9afjh7 vkn4q
28 Oct 13
Prospectus supplement for primary offering
12:00am
424B5
fdkwctzlkix73xot
23 Oct 13
Prospectus supplement for primary offering
12:00am
424B5
ko00u px2b9mdpe5
7 Oct 13
Prospectus supplement for primary offering
12:00am
- Prev
- 1
- Next